Avadel Pharmaceuticals plc
AVDL
|
$17.33
-0.29%
-0.29%
1.3M
|
Health Technology
(0.0% 1d) (1.4% 1m) (64.3% 1y) (-0.3% 2d) (-0.3% 3d) (-4.2% 7d) (20.24% volume)
Earnings Calendar:
Market Cap: $ 0
http://www.avadel.com
Sec Filling | Patents | 50 employees
(IE) Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
ft218 narcolepsy
add to watch list Paper trade email alert is off
Press-releases
Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -2.0%
conference pharmaceuticals
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.37%
H: 2.68%
C: -1.62%
pharmaceuticals
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - March 5, 2024
Published: 2024-03-05 (Crawled : 17:00) - biospace.com/
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.37%
H: 2.68%
C: -1.62%
pharmaceuticals
Avadel Pharmaceuticals Issues Statement On Patent Litigation
Published: 2024-03-04 (Crawled : 21:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.37%
H: 2.68%
C: -1.62%
patent pharmaceuticals
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: 2.04%
H: 21.43%
C: 15.21%
year update pharmaceuticals financial results
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.16%
H: 3.33%
C: 3.1%
report year update pharmaceuticals financial results
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.32%
H: 0.52%
C: -4.17%
conference life pharmaceuticals sciences
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: 6.58%
H: 8.56%
C: 1.73%
year pharmaceuticals lumryz financial
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: 10.5%
H: 11.51%
C: 1.26%
update pharmaceuticals financial results
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
Published: 2023-11-07 (Crawled : 13:00) - globenewswire.com
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -0.74%
H: 0.53%
C: -2.63%
pharmaceuticals
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001104659-24-030222 | 4 | 2024-03-04 | 2024-02-20 | Buy | A | 147000 | 147000 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10